FDA STATE_REFERRAL_LETTER - Mayo Clinic Pharmacy - August 10, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This STATE REFERRAL LETTER record concerns Mayo Clinic Pharmacy, with an inspection on August 10, 2018, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Mayo Clinic Pharmacy
Inspection Date: August 10, 2018
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Stacey Jassey
Art O. Czabaniuk (Program Division Director)
Brett R. Havranek (Investigator)
Nicholas F. Lyons (Director of Compliance)

Open in Dashboard

ID · 7fe799d0-e6bf-4094-8c44-a8efa1211fbd

Violation Codes3

21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A(a)

Full citation text and observation details available on the Dashboard.